1Corter D,O' Rourke RA.Current approaches to patients with acute coronary syndromes. Curr Prbl Cardiol 2002,27:145 ～ 184
2Pope JH ,Aufderheide TP.Ruthazer R.et al.Missed diagnoses of acute cardiac ischemia in the emergency department. N Engl J Med2000,342:1163～1170
3Boersma E ,Pieper KS ,Steyeberg EW.et al.For the pursuit investigators predictors of outcomes in patients with acute coronary syndromes without persistent ST segment elevation:Results from an international trial of 9461patients. Circulation 2000,101:2557～2567
4Danesh J, Collins R, Appleby D.et al. Association of fibrinagen, C-reactive proteia, albamen or leucocyte count with coronary heart disease mete-analyses of prospective studies JAMA 1998,279:1477～1482
5Kanl P,Fu YL,Chang WC,et al.Prognostic value of ST segment depression in acute coronary syndromes:Insights from PARACON-A applied to GUSTO- Ⅱ b J Am Coll Cardiol 2001,38:64～71
6Antman EM.Tanasijevic MJ,Thompson B.et al.Cardiac-specific troponim I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med 1996,335:1342～1349
7Braunwald E,Antman EM.Beasley TW.et al.ACC / AHA quideline update for the management of patients with unstable angina and non-ST segment elevation myocardial infarction-2002;summary aricle;a report of the American College of Cardiology / American Heart Associaion Task Force on Practice Guidelines(Committee on the Management of Unstable Angina)Circulaton 2002,106:1893 ～ 1900
8Ridker PM.Papid reduction in C-reative protein with cerivastatin among 785 patients with primary hypero1esterolemia. Circulation2001,3:1191～1193
9Schwarts GG.Olsson AG,Ezekowitz MD et al.Effects of atrovastatin on early recurrent ischemic events in acute coronary syndromes:the MIRACI.Study:a randomized controlled trial. JAHA 2001,285:1711～1718
